期刊文献+

糖尿病患者微量白蛋白尿的临床分析

Clinical Analysis of Microalbuminuria in Diabetes Patients
下载PDF
导出
摘要 目的探讨糖尿病患者微量白蛋白尿与高血压、脂代谢异常之间的关系。方法将连续入选的糖尿病住院患者分为高血压组及非高血压组,检测血甘油三酯、高密度脂蛋白、空腹血糖、2h血糖、糖化血红蛋白、空腹胰岛素、C肽、血清微球蛋白、尿微球蛋白、24h尿白蛋白排泄率。结果高血压组的UAER为(32.4±25.06)mg/24h,明显高于非高血压组(22.90±18.85)mg/24h(P<0.01),两组MAU检出率分别为43.93%、29.17%。MAU患者年龄、FPG、2hPG、HbA1c、血清β2-MG、尿β2-MG、UAER、TG明显高于正常白蛋白尿患者,两组相比差异具有统计学意义,且UAER随着患者代谢异常因素的增加而增高。结论糖尿病患者UAER增高与高血压、高TG、低HDL-C密切相关,有高危因素患者应尽早进行MAU的筛查。 Objective To discuss the relationship between microalbuminuria and hypertension and abnormal lipid metabolism. Methods The patients were divided into two groups, hypertension groups and non-hypertension groups. The serum triglyceride, high-density lipoprotein, fasting plasma glucose, 2 hours plasma glucose,glycosylated hemoglobin, fasting serum insulin, C-peptide, serum β2-microglobulin, urine β2-microglobulin, urine albumin excretion rate of 24 hours were detected. Results The UAER was higher in hypertension groups than in non-hypertension groups(P〈O.O1), MAU was 43.93% and 29.17 respectively. The age, FPG, 2hPG, HbAlc, serum β2- MG, urine β2- MG, UAER, TG were higher than normal albuminuria patients. Conclusion The increase of UAER in dibetes patients is closely related to hypertension, high TG, low HDL-C. The patients of high risk factors should screen as soon as possible.
出处 《中国现代医生》 2008年第4期11-12,共2页 China Modern Doctor
关键词 糖尿病 高血压 微量白蛋白尿 尿白蛋白排泄率 Diabetes Hypertension Microalbuminuria Urine albumin excretion rate
  • 相关文献

参考文献4

二级参考文献16

  • 1史虹莉,徐一甄,沈稚舟,杨秀芳,朱禧星.非胰岛素依赖型糖尿病患者高血压的多因素分析[J].中华内分泌代谢杂志,1996,12(3):157-159. 被引量:13
  • 2潘长玉 钱荣立 等.糖尿病合并高血压、冠心病、脑血管病.糖尿病临床指南[M].北京:北京医科大学出版社,2000.186-197.
  • 3Adrian HH,Siddals KW, William F,et al, Low circulating levels of insulin-like growth factor binding protein-1 (IGFBP-1) are closely associated with the presence of macrovascular disease and hypertension in type 2 diabetes[J].Diabetes,2002,51:2629-2636
  • 4Zachary T. Bloomgarden, Obesity, Hypertension and Insulin resistance[J].Diabetes Care,2002, 25:2088-2097
  • 5羽田胜计.糖尿病肾病[J].最新医学,2000,55(3):362-367.
  • 6hael Morcos, Ahmed A R. Sayed, Angelika Bierhaus. Activation of tubular epithelial cells in diabetic nephropathy[J].Diabetes,2002,51:3532-3544.
  • 7Aksun SA, Ozmen D, Ozmen B. Beta2-microglobulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy[J]. Exp Clin Endocrinol Diabetes,2004,112(4):195-200.
  • 8Woo,KT,Lau,YK.Pattern of proteinuria in tubular injury and glomerular hyperfiltration[J].Ann Acad Med Singapore,1997,26(4):465-470.
  • 9Bruno G, Merletti F, Biggeri.A Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study[J].Diabetes Care,2003 Jul,26(7):2150-2155.
  • 10UKPDS38.Tight blood pressure control and risk of microvascular and microvascular complication in type 2 diabetes[J].BMJ,1998,7160:703-706.

共引文献111

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部